O2 and Mavenir successfully trial technology to improve call clarity for people with hearing loss

O2 has successfully trialled new technology to provide clearer phone calls for customers with hearing loss The trial was carried out with Mavenir and created a personalised hearing profile for each participant, allowing the network to automatically optimise calls in real time Working seamlessly in the background, the technology helped overcome the everyday frustration of […]

Continue Reading

Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL

New Clinical Data, Patient Reported Outcomes, Real-World Utilization, and Comparative-Effectiveness Models to be Featured in Four Oral and One Poster Presentation PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the […]

Continue Reading

Mavenir and TextNow Win Best MVNO and Industry Collaboration at MVNOs World Awards

Award-winning collaboration delivers transformative results: eSIM activations surge from 2% to 94% in six months and paid subscribers more than double year-over-year RICHARDSON, Texas and WATERLOO, Ontario, June 08, 2026 (GLOBE NEWSWIRE) — Mavenir, the software company building mobile networks that are AI-by-design, and TextNow, the leading ad-supported U.S. free wireless service, have been jointly […]

Continue Reading